According to a 15-year study which observed about 25,000 women, the risk of developing an ovarian tumor is higher for women receiving fertility treatments with ovary-stimulating drugs.
The study, led by Flora van Leeuwen of the Netherlands Cancer Institute, found that women who underwent in-vitro fertilization, or IVF, were twice as likely to develop either ovarian cancer or a borderline tumor, which is defined as a tumor with abnormal cells that may or may not become cancerous.
Of the 25,000 women included in the study, about 19,000 received IVF treatment. Among the group that received the treatment, 61 women had an ovarian malignancy, 31 of which were borderline tumors and 30 of which were invasive ovarian cancer.
The study’s findings were published in Oxford journal Human Reproduction.
A delay in diagnosing and treating ovarian cancer or any other form of cancer may allow the cancer to grow and spread, lowering a patient’s chance beating their cancer. If you or someone you love has been harmed by a delay in diagnosing or treating cancer, our cancer malpractice attorneys can help. Your initial consultation is free and there is no fee to you unless we recover money. Please call us today, or submit an instant inquiry now and we will respond within 24 hours. Silberstein, Awad & Miklos serves clients with Queens cancer malpractice, Bronx cancer malpractice, Brooklyn cancer malpractice, Manhattan cancer malpractice and Long Island cancer malpractice cases.
No comments:
Post a Comment